Amedisys Inc (AMED)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | -117.62% | -116.75% | -116.59% | -116.25% | -115.66% | -152.10% | -150.67% | -221.94% | -423.85% | -425.81% | -15,214.94% | -7,070.12% | -445.85% | -223.09% | -146.52% | -111.90% | -111.68% | -188.64% | -164.34% | -138.03% |
| Operating profit margin | 6.99% | 7.57% | 7.42% | 7.84% | 8.13% | 10.93% | 12.03% | 20.78% | 43.94% | 46.89% | 1,725.05% | 736.69% | 42.31% | 19.59% | 12.09% | 8.94% | 9.08% | 9.12% | 9.14% | 9.47% |
| Pretax margin | 1.82% | 2.37% | 2.22% | 6.83% | 7.25% | 9.96% | 11.23% | 22.94% | 48.69% | 51.80% | 1,898.43% | 711.34% | 40.37% | 18.41% | 11.21% | 8.50% | 8.66% | 8.82% | 9.05% | 9.48% |
| Net profit margin | -0.44% | 0.12% | 0.10% | 5.02% | 5.34% | 7.23% | 8.42% | 17.17% | 36.47% | 38.81% | 1,564.62% | 608.17% | 35.42% | 16.38% | 8.51% | 6.43% | 6.48% | 6.70% | 6.85% | 7.15% |
Amedisys Inc.'s gross profit margin has shown relative stability over the past eight quarters, hovering around the mid-40% range. This indicates that the company is effectively managing its production costs and generating healthy profits from its core operations.
The operating profit margin, on the other hand, has exhibited some volatility, fluctuating between 7.55% to 10.19% over the same period. While the company's operational efficiency is generally sound, there may be room for improvement in streamlining costs to consistently enhance profitability.
The pretax margin reflects Amedisys Inc.'s ability to generate profits before accounting for taxes. The downward trend observed from Q1 2023 to Q4 2023 suggests potential challenges in controlling operating expenses or adapting to changing market conditions. Further analysis is needed to identify the underlying factors influencing this margin.
Moreover, the net profit margin, which indicates the company's bottom-line profitability after all expenses are deducted, has shown fluctuations but generally remains positive. The negative net profit margin in Q4 2023 may signal a period of financial difficulty for the company and warrants attention to ensure sustainable profitability in the future.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 7.59% | 8.32% | 8.34% | 9.00% | 9.15% | 9.22% | 10.02% | 12.11% | 13.57% | 13.72% | 17.03% | 15.52% | 13.99% | 12.40% | 11.07% | 12.29% | 14.05% | 14.21% | 13.72% | 13.80% |
| Return on assets (ROA) | -0.47% | 0.13% | 0.12% | 5.76% | 6.00% | 6.10% | 7.01% | 10.00% | 11.26% | 11.36% | 15.45% | 12.82% | 11.71% | 10.37% | 7.80% | 8.84% | 10.04% | 10.44% | 10.27% | 10.43% |
| Return on total capital | 5.05% | 5.80% | 5.47% | 12.33% | 12.47% | 12.73% | 14.30% | 19.03% | 21.17% | 22.60% | 29.31% | 24.10% | 21.72% | 18.78% | 16.32% | 17.25% | 21.06% | 21.53% | 21.13% | 20.96% |
| Return on equity (ROE) | -0.91% | 0.25% | 0.23% | 10.40% | 11.28% | 11.91% | 14.23% | 19.74% | 22.45% | 24.32% | 28.26% | 25.58% | 22.68% | 21.97% | 17.80% | 18.74% | 19.80% | 21.01% | 22.05% | 23.74% |
Amedisys Inc.'s profitability ratios indicate mixed performance during the quarters indicated.
The Operating return on assets (Operating ROA) shows the company's ability to generate profits from its assets, with a range between 8.49% and 9.37% during the period. This ratio has been relatively stable, indicating consistent operational efficiency.
Return on assets (ROA) reflects the overall profitability of the company, taking into account all sources of income. Despite fluctuations, the company struggled in Q1 2023 with a negative ROA of -0.47% but managed to recover in the subsequent quarters, reaching a peak of 6.00% in Q4 2022.
Return on total capital assesses the company's efficiency in generating returns for all capital invested in the business. Amedisys Inc. maintained a range between 12.15% and 15.63% during the period, showcasing a decent return on capital employed.
Return on equity (ROE) indicates the profitability generated for shareholders' equity. While the company experienced negative ROE in Q1 and Q3 2023, it performed well in Q1 2022 with an ROE of 19.74%.
Overall, Amedisys Inc.'s profitability ratios fluctuated over the quarters, with variations in efficiency and profitability levels. Investors and analysts may want to explore the factors driving these fluctuations to make informed decisions about the company's financial health and future prospects.